NCI, Illumina, Agendia, OGT, NMC, GenUS BioSystems, Perlegen, Glaxo | GenomeWeb

NCI Purchases Illumina BeadLab for Cancer Genotyping Studies

The National Cancer Institute has purchased genotyping instrumentation from Illumina for its Advanced Technology Center core genotyping facility in Gaithersburg, Md., the company said last week.

The facility plans to use the BeadLab station initially for research into the genetics of breast and prostate cancer and will support the NCI's Cancer Genetic Markers of Susceptibility initiative.

NCI researchers plan to genotype approximately 15,000 loci for each of more than 6,000 DNA samples.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: gene flow between ancient chimpanzees and bonobos, and more.

A startup wants to match customers to wine based on their DNA and one critic calls the idea 'silly,' Stat News reports.

Researchers trace the origins of brown rats using genetic analysis to China, the New York Times reports.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.